SkinBioTherapeutics Plc
SBTX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £338 | -£1,034 | -£1,541 | -£1,335 |
| Dep. & Amort. | £245 | £154 | £123 | £45 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£652 | £86 | -£152 | £15 |
| Other Non-Cash | -£426 | -£9 | £173 | -£91 |
| Operating Cash Flow | -£495 | -£803 | -£1,398 | -£1,365 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£75 | -£83 | -£122 | -£15 |
| Net Acquisitions | -£45 | -£1,417 | -£2,098 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | -£62 |
| Investing Cash Flow | -£121 | -£1,500 | -£2,220 | -£76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £950 | £1,472 | -£20 |
| Stock Issued | £4,244 | £1,812 | £129 | £2,991 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£85 | -£22 | -£22 | £0 |
| Financing Cash Flow | £4,158 | £2,740 | £1,578 | £2,971 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | £3,542 | £436 | -£2,040 | £1,529 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1,237 | £801 | £2,841 | £1,312 |
| End Cash | £4,779 | £1,237 | £801 | £2,841 |
| Free Cash Flow | -£499 | -£806 | -£1,411 | -£1,380 |